Beta blocker may lower risk for prostate cancer

Paul Frenette, M.D., explains his research on a beta blocker that significantly reduced men’s risk of intermediate- and low-grad prostate cancer. Dr. Frenette is professor of medicine and of cell biology, and chair and director of the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research.


Getting on Cancer's Nerves: A Surprising Way to Thwart Tumors

Paul Frenette, M.D., discusses his research that found the nervous system drives cancer growth in mice implanted with human prostate tumors. Dr. Frenette is professor of medicine and director of the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research.


The New York Times Magazine quotes Paul Frenette, M.D., in an article on research linking the nervous system to inflammation. Dr. Frenette has discovered that nerves play a key role in triggering prostate cancer, which is also associated with inflammation. Dr. Frenette is professor of medicine and of cell biology and director of the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research.


Nature features new research by Paul Frenette, M.D., that found nerves spur the development and spread of prostate cancer. The study, conducted in mice and human tissue samples, suggests that blocking certain nerve receptors could be a possible cancer treatment. Dr. Frenette is professor of medicine and of cell biology and director of the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research

More coverage on this story

The Scientist
U.S. News & World Report
Press Association (UK)
The Hindu (India)


Nature.com interviews Paul Frenette, M.D., about his research that found white blood cells play a key role in controlling red blood cell production.  Dr. Frenette notes that the findings could lead to a new therapy for polycythemia vera, a rare genetic disorder in which the bone marrow produces too many red blood cells. Dr. Frenette is director of Einstein’s Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research and professor of medicine and of cell biology.


National Geographic.com interviews Paul Frenette, M.D., about the promise and potential dangers of new research showing stem cells from young mice injected into rapidly aging older mice significantly increased life span. Dr. Frenette is director of Einstein’s Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research.